Research Article

Molecular Docking Analysis of Some Bioactive Molecules of Cistus incanus Against SARS CoV-2

Volume: 11 Number: 2 December 15, 2021
Sakine Kübra Çelik , Elvan Üstün *
TR EN

Molecular Docking Analysis of Some Bioactive Molecules of Cistus incanus Against SARS CoV-2

Abstract

Coronavirus disease affects all the world with the pandemic way that we are still living. The fight against the disease continues with vaccination all over the world. Considering the protection time and the difficulties in attaining the vaccine, in order to be successful in fighting against the disease, we need drugs that enable to kill or hinder replication of the viruses. In drug studies, after analyzing the effect of phytochemicals on the viruses, isolated phytochemical is modified in order to synthesize a more effective molecule. It is not possible to analyze the anti-viral activity of each isolated molecule by in-vitro methods, and in-silico methods can help to overcome this problem. Cistus incanus is a plant whose anti-viral activity has been confirmed by previous trials on many viruses. In this study, the interaction of myricetin 3-O-hexoside, myricitrin, quercitrin and kaempferol 3-O-rutinocide which were detected in the Cistus incanus, were analyzed by molecular docking methods with papain-like protease and main protease crystal. Strong H-bonds were detected between the investigated molecules and papain-like protease and main protease.

Keywords

COVID-19, Papain-Like Protease, Cistus incanus, Molecular Docking

References

  1. Adhikari, B., Marasini, B. P., Rayamajhee, B., Bhattarai, B. J., Lamichhane, G., Khadayat, K., Adhikari, A., Khanal, S., and Parajuli,N. (2020). Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID-19: A review. Phytotherapy Research, 35, 1298–1312.
  2. Alfaro, M., Alfaro, I., & Angel, C. (2020). Identification of potential inhibitors of SARS-CoV-2 papain-like proteasefrom tropane alkaloids from Schizanthus porrigens: A moleculardocking study. Chemical Physics Letters, 761, 138068.Tallei, T. E., Tumilaar, S. G., Niode, N. J., Fatimawali, Kepel, B. J., Idroes, R., Effendi, Y., Sakib, S. A., Emran, T. B. (2020). Potential of plant bioactive compounds as SARS-CoV-2 main protease (Mpro) and spike (S) glycoprotein inhibitors: A molecular docking study". Scientifica, Article ID 6307457.
  3. Ali, A. M., and Kunugi, H. (2021). Propolis, bee honey, and their components protect against coronavirus disease 2019 (COVID-19): A Review of in silico, in vitro, and clinical studies”, Molecules, 26, 1232.
  4. Antonio, A. S., Wiedemann, L. S. M., and Veiga-Junior, V. F. (2020). Natural products' role against COVID-19. RSC Advances, 10, 23379.
  5. Attaguile, G., Russo, A., Campisi, A., Savoca, F., Acquaviva, R., Ragusa, N, and Vanella, A. (2000). Antioxidant activity and protective effect on DNA cleavage of extracts from Cistus incanus L. and Cistus monspeliensis L. Cell Biology and Toxicology, 16, 83 - 90.
  6. Banerjee, A., Santra, D., & Maiti,S. (2020). Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immune informatic analysis implicating for a suitable vaccine development. Journal of Translational Medicine, 18, 281.
  7. Banerjee, R., Perera, L., and Tillekeratne, L. M. V. (2021). Potential SARS-CoV-2 main protease inhibitors. Drug Discovery Today, 26(3).
  8. Barrajón-Catalán, E., Fernández-Arroyo, S., Saura, D., Guillén, E., Fernández- Gutiérrez, A., Segura-Carretero, A. (2010). Cistaceae aqueous extracts containing ellagitannins show antioxidant and antimicrobial capacity, and cyto- toxic activity against human cancer cells. Food Chemistry and Toxicology, 48. 2273–2282. doi: 10.1016/j.fct.2010.05.060.
  9. Barros, L., Dueñas, M., Alves, C. T., Silva, S., Henriques, M., Santos-Buelga, C. (2013). Antifungal activity and detailed chemical characterization of Cistus ladanifer phenolic extracts. Industrial Crops and Products, 41. 41–45. doi: 10.1016/j.indcrop.2012.03.038.
  10. Behl, T., Rocchetti, G., Chadha, S., Zengin, G., Bungau, S., Kumar, A., Mehta, V., Uddin, S., Khullar, G., Setia, D., Arora, S., Sinan, K. I., Ak, G., Putnik, P., Gallo,M., and Montesano, D. (2021). Phytochemicals from plant foods as potential source ofantiviral agents: an overview. Pharmaceuticals, 14, 381.
APA
Çelik, S. K., & Üstün, E. (2021). Molecular Docking Analysis of Some Bioactive Molecules of Cistus incanus Against SARS CoV-2. Karadeniz Fen Bilimleri Dergisi, 11(2), 522-532. https://doi.org/10.31466/kfbd.939421
AMA
1.Çelik SK, Üstün E. Molecular Docking Analysis of Some Bioactive Molecules of Cistus incanus Against SARS CoV-2. KFBD. 2021;11(2):522-532. doi:10.31466/kfbd.939421
Chicago
Çelik, Sakine Kübra, and Elvan Üstün. 2021. “Molecular Docking Analysis of Some Bioactive Molecules of Cistus Incanus Against SARS CoV-2”. Karadeniz Fen Bilimleri Dergisi 11 (2): 522-32. https://doi.org/10.31466/kfbd.939421.
EndNote
Çelik SK, Üstün E (December 1, 2021) Molecular Docking Analysis of Some Bioactive Molecules of Cistus incanus Against SARS CoV-2. Karadeniz Fen Bilimleri Dergisi 11 2 522–532.
IEEE
[1]S. K. Çelik and E. Üstün, “Molecular Docking Analysis of Some Bioactive Molecules of Cistus incanus Against SARS CoV-2”, KFBD, vol. 11, no. 2, pp. 522–532, Dec. 2021, doi: 10.31466/kfbd.939421.
ISNAD
Çelik, Sakine Kübra - Üstün, Elvan. “Molecular Docking Analysis of Some Bioactive Molecules of Cistus Incanus Against SARS CoV-2”. Karadeniz Fen Bilimleri Dergisi 11/2 (December 1, 2021): 522-532. https://doi.org/10.31466/kfbd.939421.
JAMA
1.Çelik SK, Üstün E. Molecular Docking Analysis of Some Bioactive Molecules of Cistus incanus Against SARS CoV-2. KFBD. 2021;11:522–532.
MLA
Çelik, Sakine Kübra, and Elvan Üstün. “Molecular Docking Analysis of Some Bioactive Molecules of Cistus Incanus Against SARS CoV-2”. Karadeniz Fen Bilimleri Dergisi, vol. 11, no. 2, Dec. 2021, pp. 522-3, doi:10.31466/kfbd.939421.
Vancouver
1.Sakine Kübra Çelik, Elvan Üstün. Molecular Docking Analysis of Some Bioactive Molecules of Cistus incanus Against SARS CoV-2. KFBD. 2021 Dec. 1;11(2):522-3. doi:10.31466/kfbd.939421